While EMT and decreased E-cadherin levels can explain some cases of cancer progression, there are still instances where cancer cells maintain E-cadherin expression on their cell surface, do not undergo EMT and are still able to facilitate metastatic outgrowth at a distant site [6–8]. The gene discussed is CDH1; the disease is cancer.